Core Viewpoint - CardioComm Solutions Inc. has announced that its CEO, Mr. Etienne Grima, has purchased a loan worth $80,000 from a third-party lender, consolidating all of the company's debt under insider control, which reflects management's confidence in the company's strategic direction [1][3]. Debt Consolidation - The loan purchased by the CEO is part of original loans totaling $600,000, first disclosed on December 21, 2016, with portions of the debt progressively retired over time [2]. - Following this transaction, all of CardioComm's debt is now held by insiders, enhancing the company's ability to advance its commercialization plans without reliance on external debt providers [3]. Loan Terms and Approval - The terms of the loan remain unchanged, and the acquisition does not affect the company's financial reporting obligations. The transaction was unanimously approved by the company's directors [4][6]. - This transaction is classified as a private asset purchase and does not constitute a "related party transaction" under Multilateral Instrument 61-101, thus not requiring TSX Venture Exchange approval [7]. Transparency and Compliance - The company is voluntarily disclosing this transaction to ensure transparency for shareholders and to comply with the requirements of Leede Financial Inc., which previously administered the loan [5].

Core Insights - CardioComm Solutions, Inc. has completed a shares-for-debt transaction with its four directors, issuing a total of 4,162,500 common shares at a price of $0.01 per share to settle $41,625 in outstanding debt [1] - The debt was incurred for services provided by the directors in 2024 and the first half of 2025 [1] Debt Settlement Details - Etienne Grima received 1,192,500 shares for $11,925 of debt - Robert Caines received 1,230,000 shares for $12,300 of debt - Daniel Grima received 1,080,000 shares for $10,800 of debt - Robin Black received 660,000 shares for $6,600 of debt [1] Regulatory Compliance - The shares issued are subject to a four-month hold period, expiring on December 1, 2025, in accordance with securities laws and TSX Venture Exchange policies [2] - Each transaction is classified as a "related party transaction" under Multilateral Instrument 61-101, exempt from formal valuation and minority shareholder approval as the fair market value does not exceed 25% of the company's market capitalization [3] Company Overview - CardioComm Solutions specializes in consumer heart monitoring and medical ECG software solutions, with patented technology for recording, viewing, analyzing, and storing electrocardiograms [5] - The company has earned ISO 13485 and ISO 27001 certifications, is HIPAA compliant, and holds medical device clearances from the USA (FDA) and Canada (Health Canada) [5]